[1]陈旭 综述 尚攀峰* 审校.局限性肾癌术后复发与手术相关因素的研究进展[J].中国微创外科杂志,2022,01(11):903-908.
点击复制

局限性肾癌术后复发与手术相关因素的研究进展()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2022年11期
页码:
903-908
栏目:
文献综述
出版日期:
2023-02-23

文章信息/Info

作者:
陈旭 综述 尚攀峰* 审校
(兰州大学第二医院泌尿外科，兰州730030)
文献标志码:
B

参考文献/References:

[1]Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a populationbased to a more "personalized" approach to cancer staging. CA Cancer J Clin,2017,67(2):93-99.
[2]刘昕,王志勇,迟强,等.循环肿瘤细胞和循环肿瘤内皮细胞计数对局限性肾癌术后复发转移监测的价值.现代肿瘤医学,2022,30(4):663-666.
[3]Klatte T, Rossi SH, Stewart GD. Prognostic factors and prognostic models for renal cell carcinoma: a literature review. World J Urol,2018,36(12):1943-1952.
[4]Ljungberg B, Albiges L, AbuGhanem Y, et al. European Association of Urology Guidelines on renal cell carcinoma: The 2022 update. Eur Urol,2022,82(4):399-410.
[5]Lee H, Oh JJ, Byun SS, et al. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity scorematched study. Urol Oncol,2017,35(6):379-385.
[6]Speed JM, Trinh QD, Choueiri TK, et al. Recurrence in localized renal cell carcinoma: a systematic review of contemporary data. Curr Urol Rep,2017,18(2):15.
[7]Gershman B, Thompson RH, Boorjian SA, et al. Radical versus partial nephrectomy for cT1 renal cell carcinoma. Eur Urol,2018,74(6):825-832.
[8]Yang C, Liao Z. Comparison of radical nephrectomy and partial nephrectomy for T1 renal cell carcinoma: A metaanalysis. Urol Int,2018,101(2):175-183.
[9]Lai TC, Ma WK, Yiu MK. Partial nephrectomy for T1 renal cancer can achieve an equivalent oncological outcome to radical nephrectomy with better renal preservation: the way to go. Hong Kong Med J,2016,22(1):39-45.
[10]Jiang YL, Peng CX, Wang HZ, et al. Comparison of the longterm followup and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma: a systematic review and metaanalysis. BMC Urol,2019,19(1):48.
[11]Kreshover JE, Richstone L, Kavoussi LR. Renal cell recurrence for T1 tumors after laparoscopic partial nephrectomy. J Endourol,2013,27(12):1468-1470.
[12]Deng W, Chen L, Wang Y, et al. Partial nephrectomy versus radical nephrectomy for large (≥7cm) renal tumors: A systematic review and metaanalysis. Urol Oncol,2019,37(4):263-272.
[13]Rinott Mizrahi G, Freifeld Y, Klein I, et al. Comparison of partial and radical laparascopic nephrectomy: Perioperative and oncologic outcomes for clinical T2 renal cell carcinoma. J Endourol,2018,32(10):950-954.
[14]Mir MC, Derweesh I, Porpiglia F, et al. Partial nephrectomy versus radical nephrectomy for clinical t1b and T2 renal tumors: A systematic review and metaanalysis of comparative studies. Eur Urol,2017,71(4):606-617.
[15]Li J, Zhang Y, Teng Z, et al. Partial nephrectomy versus radical nephrectomy for cT2 or greater renal tumors: a systematic review and metaanalysis. Minerva Urol Nefrol,2019,71(5):435-444.
[16]Alanee S, Nutt M, Moore A, et al. Partial nephrectomy for T2 renal masses: contemporary trends and oncologic efficacy. Int Urol Nephrol,2015,47(6):945-950.
[17]De Saint Aubert N, Audenet F, Mccaig F, et al. Nephron sparing surgery in tumours greater than 7cm. Prog Urol,2018,28(6):336-343.
[18]徐虎,王福利,袁建林.肾癌患者后腹腔镜下肾部分切除术的预后相关因素分析.中华泌尿外科杂志,2017,38(8):591-594.
[19]Kim H, Kim JK, Ye C, et al. Recurrence after radical and partial nephrectomy in high complex renal tumor using propensity score matched analysis. Sci Rep,2021,11(1):2919.
[20]Rouffilange J, Gobet A, Capon G, et al. Partial nephrectomy for renal masses >7cm: Morbidity, oncological and functional outcomes (UroCCR7 study). Prog Urol,2018,28(12):588-595.
[21]Bradshaw AW, Autorino R, Simone G, et al. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity scorematched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. BJU Int,2020,126(1):114-123.
[22]Banapour P, Abdelsayed GA, BiderCanfield Z, et al. Nephrometry score matched robotic vs. laparoscopic vs. open partial nephrectomy. J Robot Surg,2018,12(4):679-685.
[23]Auffenberg GB, Curry M, Gennarelli R, et al. Comparison of cancer specific outcomes following minimally invasive and open surgical resection of early stage kidney cancer from a national cancer registry. J Urol,2020,203(6):1094-1100.
[24]Mukkamala A, He C, Weizer AZ, et al. Longterm oncologic outcomes of minimally invasive partial nephrectomy for renalcell carcinoma. J Endourol,2014,28(6):649-654.
[25]Tam AW, Kutikov A, Winoker JS, et al. Propensityscore matched oncological outcomes and patterns of recurrence following open and minimallyinvasive partial nephrectomy for renal cell carcinoma. Urol Oncol,2022,40(3):111 e19-e25.
[26]Golombos DM, Chughtai B, Trinh QD, et al. Minimally invasive vs open nephrectomy in the modern era: does approach matter? World J Urol,2017,35(10):1557-1568.
[27]Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: AUA guideline. J Urol,2017,198(3):520-529.
[28]Shibamori K, Hashimoto K, Shindo T, et al. Outcomes of open partial nephrectomy for renal cell carcinoma in the minimally invasive approach era. Curr Urol,2021,15(4):198-203.
[29]Yin H, Zhou Z, Liu Q, et al. Laparoscopic radical resection for largevolume renal carcinoma: via retroperitoneal or transperitoneal approach? J BUON,2021,26(3):1094-1101.
[30]Arora S, Heulitt G, Menon M, et al. retroperitoneal vs transperitoneal robotassisted partial nephrectomy: Comparison in a multiinstitutional setting. Urology,2018,120:131-137.
[31]Mittakanti HR, Heulitt G, Li HF, et al. Transperitoneal vs. retroperitoneal robotic partial nephrectomy: a matchedpaired analysis. World J Urol,2020,38(5):1093-1099.
[32]Bauza JL, Tubau V, Guimera J, et al. Retroperitoneoscopic approach for highly complex posterior renal hilar tumors. Int Braz J Urol,2020,46(3):485-486.
[33]Choi CI, Kang M, Sung HH, et al. Comparison by pentafecta criteria of transperitoneal and retroperitoneal robotic partial nephrectomy for large renal tumors. J Endourol,2020,34(2):175-183.
[34]Ha US, Hwang TK, Kim YJ, et al. Comparison of oncological outcomes of transperitoneal and retroperitoneal laparoscopic radical nephrectomy for the management of clearcell renal cell carcinoma: a multiinstitutional study. BJU Int,2011,107(9):1467-172.
[35]Pavan N, Derweesh I, Hampton LJ, et al. Retroperitoneal robotic partial nephrectomy: Systematic review and cumulative analysis of comparative outcomes. J Endourol,2018,32(7):591-596.
[36]Alemozaffar M, Filson CP, Master VA. The importance of surgical margins in renal cell and urothelial carcinomas. J Surg Oncol,2016,113(3):316-322.
[37]Lai GS, Li JR, Wang SS, et al. Survival analysis of pathological T3a upstaging in clinical t1 renal cell carcinoma. In Vivo,2020,34(2):799-805.
[38]AbuGhanem Y, Ramon J, Berger R, et al. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and diseasespecific survival. World J Surg Oncol,2017,15(1):193.
[39]Morris LK, Altahan A, Gandhi J, et al. Impact of margin status on survival after radical nephrectomy for renal cell carcinoma. J Surg Oncol,2021,123(2):687-692.
[40]Marchinena PG, Tirapegui S, Gonzalez IT, et al. Positive surgical margins are predictors of local recurrence in conservative kidney surgery for pT1 tumors. Int Braz J Urol,2018,44(3):475-482.
[41]FernándezConcha Schwalb JJ, Pérez Reggeti JI, López Costea MA, et al. Positive margins after partial nephrectomy in renal cell carcinoma: Oncological outcomes of conservative management after longterm followup. Actas Urológicas Espaolas(English Edition),2019,43(8):414-418.
[42]Kang HW, Lee SK, Kim WT, et al. Surgical margin does not influence recurrence rate in pT1 clear cell renal cell carcinoma after partial nephrectomy: A multicenter study. J Surg Oncol,2016,114(1):70-74.
[43]Antic T, Taxy JB. Partial nephrectomy for renal tumors: lack of correlation between margin status and local recurrence. Am J Clin Pathol,2015,143(5):645-651.
[44]Petros FG, Metcalfe MJ, Yu KJ, et al. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25year single institution experience. World J Urol,2018,36(7):1093-1101.
[45]张栋,姚立锋.肾部分切除后切缘阳性的临床研究进展.国际泌尿系统杂志,2019,39(2):345-347.
[46]Foschi N, Vittori M, Sacco E, et al.Positive surgical margins in nephron sparing surgery for renal cell carcinoma. Urologia,2014,81(1):30-39.
[47]张乐飞,易发现.肾部分切除术的研究进展.中国微创外科杂志,2020,20(2):164-167.
[48]John NT, Blum KA, Hakimi AA. Role of lymph node dissection in renal cell cancer. Urol Oncol,2019,37(3):187-192.
[49]Luo X, Li JX, Liu YT, et al. Influence of lymph node dissection in patients undergoing radical nephrectomy for nonmetastatic renal cell carcinoma: a systematic review and metaanalysis. European review for medical and pharmacological sciences,2019,23(14):6079-6090.
[50]Dell’Oglio P, Larcher A, Muttin F, et al. Lymph node dissection should not be dismissed in case of localized renal cell carcinoma in the presence of larger diseases. Urol Oncol,2017,35(11):662.e9-662.e15.
[51]Capitanio U, Leibovich BC. The rationale and the role of lymph node dissection in renal cell carcinoma. World J Urol,2017,35(4):497-506.
[52]Capitanio U, Becker F, Blute ML, et al. Lymph node dissection in renal cell carcinoma. Eur Urol,2011,60(6):1212-1220.53Feuerstein MA, Kent M, Bazzi WM, et al. Analysis of lymph node dissection in patients with ≥7cm renal tumors. World J Urol,2014,32(6):1531-1536.

备注/Memo

备注/Memo:
*通讯作者，Email:shangpf@lzu.edu.cn
更新日期/Last Update: 2023-02-23